← SearchValidating PLCG2 as a target for the treatment of Alzheimer's Disease through cell biology and pharmacological tools$38,513F31FY2024AGNIHIndiana University Indianapolis, Indianapolis INInvestigatorsLogan BedfordcontactView original record on NIH RePORTER →